GreenLight Biosciences Banner Image

GreenLight Biosciences

  • Ticker GRNA
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
GreenLight Biosciences Logo Image
  • 201-500 Employees
  • Based in Medford, Massachusetts
GreenLight Biosciences aims to address some of the world’s biggest problems by delivering on the full potential of RNA for human health and agriculture. Their RNA platform allows them to research, design, and manufacture for human, animal, and plant health. In human health, this includes messenger RNA vaccines and therapeutics. In agriculture, this includes RNA to protect honeybees andMore a range of crops. The Company’s platform is protected by numerous patents. GreenLight’s human health product candidates are in the pre-clinical stage, and its product candidates for the agriculture market are in the early stages of development or regulatory review. GreenLight is a public benefit corporation that trades under the ticker GRNA on Nasdaq.
5.0 / 5.0 (1)

GreenLight Biosciences reports have an aggregate usefulness score of 5.0 based on 1 reviews.

GreenLight Biosciences

Most Recent Annual Report

GreenLight Biosciences
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

GreenLight Biosciences Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!